We have an exciting opportunity for a Postdoctoral Researcher to work in the laboratories of Dr Anne Kiltie and Professor Eleanor Stride. You will be part of two enthusiastic research teams investigating the role of DNA damage signaling and DNA repair. The primary aim of this post is to develop an encapsulated delivery method for chemotherapy drugs using micro/nanobubble technology for use in vivo, in an orthotopic bladder cancer model, in combination with ionising radiation.
Cong Li from the Key Laboratory of Smart Drug Delivery, Ministry of Education, School of Pharmacy, Fudan University, Shanghai 201203, China
Recent adaptation of the CRISPR/Cas9 bacterial system to facilitate manipulation of mammalian genomes has provided a real breakthrough for genome editing applications. Development of whole-genome CRISPR libraries with the aim of generating gene knockouts for every single coding sequence has allowed forward genetic screening in mammalian cells with unprecedented efficiency and versatility. CRISPR/Cas9 approaches, however, rely on phenotypes associated with loss-of-function mutations.
We are seeking to recruit a Finance Assistant to join our Finance team which provides an important service to the Department of Oncology’s research scientists who are taking forward new developments to improve our knowledge of cancer.
The post involves using the University’s finance system, Oracle R12, to order supplies and manage payment of invoices to our many suppliers. The office environment is busy and dynamic with a high volume of activity on a daily basis.
Fax: +44 (0)1865 227 039
The Cancer Research UK Oxford Centre has been awarded Major Centre status by Cancer Research UK. The award was made in recognition of the world-leading science taking place in Oxford, the innovative collaborations by Centre members, and the power of the cancer research network that has already been established. As a result of the award, the Centre will receive an extra £5 million in funding over the next 2 years.